Global AI, Bio-Health, and 5G Innovation Competition Launched by HICOOL in Beijing

Go back to Global AI, Bio-Health, and 5G Innovation Competition Launched by HICOOL in Beijing

Baidu (BIDU) PT Raised to $145 at KeyBanc As the Company Begins Recovery from COVID-19

May 20, 2020 6:59 AM EDT

KeyBanc analyst Hans Chung raised the price target on Baidu (NASDAQ: BIDU) to $145.00 (from $136.00) while maintaining a Overweight rating.Though ad demand for offline related business has not fully recovered from the COVID-19 pandemic, recovery is tracking ahead of expectations.

1Q's Total... More

Mizuho Securities Reiterates Buy Rating on Baidu (BIDU) Following 1Q

May 19, 2020 7:04 AM EDT

Mizuho Securities analyst James Lee reiterated a Buy rating and $175.00 price target on Baidu (NASDAQ: BIDU) following the company's 1Q. Baidu beat core operating profit estimates by >60% on strong cost controls and provided encouraging signs of near-term revenue recovery.

During revenue uncertainty, management... More